Knotless Tissue Control Devices Market Analysis

  • Report ID: 4237
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Knotless Tissue Control Devices Market Segmentation:

The global knotless tissue control devices market is segmented and analyzed for demand and supply by application into hospitals, ambulatory surgical centers, trauma centers, medical device manufacturers, pharmaceutical companies, research centers and laboratories, and others. Out of these, the hospital segment is expected to garner the highest revenue by 2035, owing to the high number of hospitals across the world. A recent study revealed that in 2020, the hospitals in Colombia region had the highest number with 10,900 hospitals. Further, Japan had 8,240 hospitals and the United States had 6,090 hospitals in the same period. Additionally, the growing hospital industry is another growth factor expanding the market size. Hospitals increased tremendously during the pandemic and the increasing health issues that require surgery or hospitalization increased the demand for hospitals. The time of recovery from surgery is more than a week in major incidents which drives the growth of the hospital segment compared to others and is estimated to propel the growth of the market in the coming years.

The global knotless tissue control devices market is also segmented and analyzed for demand and supply by product type into short-term, long-term, and nonabsorbable polymers. Amongst these segments, the nonabsorbable polymers segment is expected to garner a significant share. The increasing number of orthopedic procedures and surgeries is estimated to drive market growth during the forecast period. Over 6 million orthopedic surgical procedures are performed every year in the United States as of 2021. Nonabsorbable polymers are used when the wound requires high tensile strength to hold to the tissue and can be easily removed from the site of surgery. Most of the wounds on the external surface of the skin require a strong tensile strength to hold the cut tissue in place during the healing process. Additionally, the removal of the sutures is helpful to avoid any foreign material attachment at the site of a wound. The presence of absorbable sutures will take a longer time to dissolve into the skin when a strong thread is used which may cause infection. While the use of nonabsorbable polymer sutures can be removed after a certain period of time and allow the tissue to heal by itself without any complications.

Our in-depth analysis of the global knotless tissue control devices market includes the following segments:

           By Product Type

  • Short-term
  • Long-term
  • Nonabsorbable polymers

          By Application

  • Hospitals
  • Ambulatory Surgical Centers
  • Trauma Centers
  • Medical Device Manufacturers
  • Pharmaceutical Companies
  • Research Centers and Laboratory
  • Others

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of knotless tissue control devices is evaluated at USD 526.7 million.

The global knotless tissue control devices market size was worth over USD 512.4 million in 2025 and is poised to grow at a CAGR of around 3.1%, reaching USD 695.34 million revenue by 2035.

North America’s knotless tissue control devices market will hold around 41% share by 2035, fueled by the rising cases of chronic diseases and increasing surgical procedures, leading to higher demand for knotless tissue control devices.

Key players in the market include Medtronic, Johnson & Johnson Services, Inc., Medical Device Business Services, Inc. (Johnson & Johnson Services, Inc.), Medline Industries, LP, Dalent LLC, Acera Surgical, Kerecis, Guard Medical Inc., Axio Biosolutions Pvt Ltd, Grapheal, Smith & Nephew.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos